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Background: Presence of pain may impair knee full extension in weight-bearing antero-posterior radiographs using such 
patient positioning and view, in osteoarthritis (OA) disease modification studies. 
Objectives: To assess whether improvement in knee pain improved the fully extended knee position, resulting in an artifactual 
increase in joint space width (JSW) in two recent trials showing symptom and joint structure modification with glucosamine sulfate 
(GS) (1,2). 
Methods: 212 and 202 patients with knee OA (ACR criteria), respectively (total 414), were randomised to double-blind 
treatment with oral GS 1500 mg u.i.d. or placebo for 3 years. JSW was assessed with the aid of a magnifying lens at the narrowest 
point of the medial compartment of the tibio-femoral joint, and symptoms were assessed by the WOMAC index. For the purpose of 
this analysis, 3-year completers were selected based on a cut-off of improvement in the WOMAC pain subscale equal to the mean 
improvement observed in the GS group in each study. The average improvement in WOMAC pain and the mean (ES) change in 
JSW were calculated for these patient subsets and compared between treatment groups. 
Results: Data in the combined analysis reported here reflect the results in each study, that were similar. There were obviously 
more patients above the selected pain improvement threshold with GS (74 vs 56 with placebo, in the two studies combined), but the 
two subsets has a similar baseline level of mild to moderate pain and JSW around 4 mm, similarly to the overall treatment groups. 
Notwithstanding a major decrease in WOMAC pain of comparable size in both patient subsets, -59% with GS vs -51% with placebo 
(NS), the placebo patients underwent a definite joint space narrowing (JSN) of -0.23 (0.11) mm that was not observed with GS, 
+0.14 (0.06) mm: p=0.005. 
Conclusion: Major relief in mild to moderate pain is not a confounder in the evaluation of JSN on weight-bearing knee 
radiographs taken in full extension. The structure modifying effect of GS is not an artifact of the drug symptomatic activity.1. 
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